| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |